Refine
Has Fulltext
- yes (120)
Is part of the Bibliography
- yes (120)
Year of publication
Document Type
- Journal article (120) (remove)
Language
- English (120) (remove)
Keywords
- Neisseria meningitidis (13)
- Echinococcus (6)
- Tanzania (6)
- meningococcal disease (6)
- Aspergillus (4)
- Germany (4)
- antimicrobial resistance (4)
- neisseria meningitidis (4)
- stem cells (4)
- COVID-19 (3)
- MRSA (3)
- Meningitis (3)
- SARS-CoV-2 (3)
- infection (3)
- inflammation (3)
- meningitis (3)
- multilocularis (3)
- ARONJ (2)
- Apoptosis (2)
- BDG (2)
- C5aR1 (2)
- Candida auris (2)
- Echinococcosis (2)
- Fusarium (2)
- Group B Streptococcus (2)
- HBMEC (2)
- Haemophilus influenzae (2)
- Neisseria gonorrhoeae (2)
- Rhizopus (2)
- Stem cell (2)
- Ureaplasma parvum (2)
- Ureaplasma urealyticum (2)
- alveolar echinococcosis (2)
- antigen (2)
- antigen testing (2)
- antimicrobial stewardship (2)
- bacteria (2)
- bacterial meningitis (2)
- bacterial pathogens (2)
- beta-D-glucan (2)
- blood–brain barrier (2)
- brain endothelial cells (2)
- candidemia (2)
- colonization (2)
- comparative genomics (2)
- diagnosis (2)
- echinococcus multilocularis (2)
- galactomannan (2)
- gene conversion (2)
- gene expression (2)
- genome sequencing (2)
- granulocytes (2)
- haemophilus influenzae (2)
- homologous recombination (2)
- infection control (2)
- men who have sex with men (2)
- microbiology (2)
- neuroinflammation (2)
- neutrophils (2)
- osteonecrosis of the jaw (2)
- osteoradionecrosis (2)
- outer membrane protein (2)
- pathogens (2)
- platyhelminthes (2)
- sepsis (2)
- serology (2)
- sphingolipids (2)
- surgical site infection (2)
- transcriptome (2)
- 5-methyl cytosine (1)
- Acetylated tubulin (1)
- Alkaline phosphatase (1)
- Alternaria (1)
- Argonaute (1)
- Ascaris lumbricoides (1)
- Aspergillus fumigatus (1)
- AurisID (1)
- B neisseria meningitidis (1)
- BacT/ALERT (1)
- Bacterial meningitis (1)
- Benzimidazoles (1)
- Biohazard (1)
- Brain endothelial cells (1)
- Brugia Malayi (1)
- C-reactive protein (1)
- C3a (1)
- C3aR (1)
- C5a (1)
- C5aR2 (1)
- CCL3 (1)
- CCL4 (1)
- CCL5 (1)
- COVID-19 testing (1)
- COVID‐19 (1)
- CPG binding domain (1)
- Calibration (1)
- Cancer treatment (1)
- Candida albicans (1)
- Candida lusitaniae (1)
- Caspase (1)
- Ceramide (1)
- Cestoda (1)
- Cestoda Taeniidae (1)
- Cestode (1)
- Chagas disease (1)
- Circinella (1)
- Clinical prediction rule (1)
- Colombia (1)
- Colonization (1)
- Community-acquired methicillin-resistant Staphylococcus aureus (1)
- DNA methylation (1)
- DNA recombination (1)
- Densovirus (1)
- Disaster response (1)
- ESBL (1)
- Efflux transport (1)
- Elderly (1)
- Emergence (1)
- Enterobacteriaceae (1)
- Epigenetic (1)
- Escherichia coli K1 (1)
- Escherichia coli infections (1)
- Europe (1)
- Expansion microscopy (1)
- False positive reactions (1)
- FinO family (1)
- Fks1 (1)
- FoxQ2 (1)
- Fungiplex Candida Auris (1)
- GM (1)
- Gene silencing (1)
- Geriatric care (1)
- Geriatrics (1)
- Germinative cell (1)
- Golgi (1)
- HFQ (1)
- HIV (1)
- Hospital emergency plan (1)
- Host-parasite interaction (1)
- Host-pathogen interactions (1)
- I-lactate (1)
- IA (1)
- ICM (1)
- IDSA (1)
- IMD (1)
- IctP (1)
- Inducible Clindamycin Resistance (1)
- Infection control (1)
- Insulin (1)
- Jurkat cells (1)
- Kinase inhibitor (1)
- LTR retrotransposons (1)
- Larvae (1)
- Lichtheimia (1)
- Listeria monocytogenes (1)
- MITE (1)
- MLST (1)
- MRONJ (1)
- MSIS (1)
- Mass critical care (1)
- Medicine (1)
- Medizin (1)
- Meningococcal infection (1)
- Meningococcal polysaccharide caccine (1)
- Meningococcal serogroup C (1)
- Meningococci (1)
- Mesocestoides corti (1)
- Metacestode (1)
- Methicillin resistant Staphylococcus aureus (1)
- Methicillin-resistant Staphylococcus aureus (1)
- Methicillin-resistant staphylococcus aureus (1)
- Mikrobiologie (1)
- Mobile genetic element (1)
- Mucin (1)
- Mucor (1)
- Mucorales (1)
- Multiplex PCR (1)
- Mwanza (1)
- Mycobacterium marinum (1)
- N-oleoyl serinol (1)
- NAS (1)
- Nanos (1)
- Nasal Carriage (1)
- Neisseria (1)
- Neoblast (1)
- Nervous system (1)
- Neuroinfectiology (1)
- Neuroinflammation (1)
- Neuropeptide (1)
- Nursing homes (1)
- ONJ (1)
- One Health (1)
- P-glycoprotein (1)
- P-gp (1)
- P. aeruginosa (1)
- PMNs (1)
- Parvovirus (1)
- Pathogens (1)
- Pentastomiasis (1)
- Pneumococci (1)
- Predictive value of tests (1)
- Prevalence (1)
- Protoscolex (1)
- Purpureocillium (1)
- RNA (1)
- RNA chaperone Hfq (1)
- Receptor kinase (1)
- Rhizomucor (1)
- S. aureus (1)
- SARS‐CoV‐2 (1)
- SFRP (1)
- ST 772 (1)
- ST1797 (1)
- ST88 (1)
- Scedosporium (1)
- Schistosoma mansoni (1)
- Sequence motif analysis (1)
- Serotonin (1)
- Sierra Nevada (1)
- Six3/6 Wnt (1)
- Skin (1)
- Staphylococcus aureus (1)
- Stem cells (1)
- Streptococcus agalactiae (1)
- Streptococcus suis (1)
- Surgery (1)
- T Cells (1)
- T cells (1)
- TGF-BETA (1)
- TNF-alpha (1)
- Talaromyces (1)
- Tapeworm (1)
- Tropheryma whipplei (1)
- Tuberculosis (1)
- Ureaplasma (1)
- Ureaplasma species (1)
- Vaccination (1)
- Valentine Leukocidin Genes (1)
- Vesicles (1)
- WBC (1)
- Whipple's disease (1)
- Xenopus oocytes (1)
- acute watery diarrhea (1)
- admission screening (1)
- agar (1)
- agar diffusion test (1)
- alloSCT patients (1)
- alternative pig farming (1)
- alveoar echinococcosis (1)
- ampicillin (1)
- anaphylatoxins (1)
- anidulafungin (1)
- antero-posterior axis (1)
- antibiotic bone concentration (1)
- antibiotic prescription behavior (1)
- antibiotic use (1)
- antibodies (1)
- anticoagulants (1)
- antifungal susceptibility (1)
- antifungals (1)
- antigen-B (1)
- antigens (1)
- antimicrobial responses (1)
- antimicrobials (1)
- antiresorptive drug-related osteonecrosis of the jaw (1)
- anxiety (1)
- assay (1)
- attitude of health personnel (1)
- atypical chemokine receptor 3 (1)
- aureus infections (1)
- autochthonous infection (1)
- azole resistance (1)
- bactericidal activity (1)
- benzimidazole (1)
- beta-lactam (1)
- beta-tubulin (1)
- beta‐d‐glucan (1)
- biological techniques (1)
- biomarker (1)
- biosynthesis (1)
- blood (1)
- blood fluke (1)
- blood stream infections (1)
- blood-brain barrier (1)
- blood-cerebrospinal fluid barrier (1)
- bloodstream infection (1)
- brain barrier (1)
- brain endothelial cell (1)
- breakthrough (1)
- bronchoalveolar lavage fluid (1)
- campylobacteriosis (1)
- cardiovascular MRI (1)
- caspase-3 (1)
- caspofungin (1)
- cell staining (1)
- cell wall (1)
- cells (1)
- central-nervous-system (1)
- cephalosporin-resistant gram-negative bacteria (1)
- ceramide (1)
- ceramide analogs (1)
- cestodes (1)
- chaperone (1)
- chemical properties (1)
- chemotherapy (1)
- children (1)
- chorioamnionitis (1)
- choroid-plexus (1)
- circulating (1)
- coagulase-negative staphylococci (1)
- commercial kits (1)
- community settings (1)
- complement system (1)
- complex (1)
- cord blood (1)
- corticosteroids (1)
- cryptic (1)
- cutibacteria (1)
- cytokines (1)
- dRNA-seq (1)
- dendritic cells (1)
- depression (1)
- detection limits (1)
- differential age distribution (1)
- digital phenotyping (1)
- disease-associated (1)
- dual function (1)
- echinocandin (1)
- echinocandins (1)
- echinococcosis (1)
- ecological momentary assessment (1)
- ecology (1)
- efflux pumps (1)
- elucidation (1)
- endophthalmitis (1)
- endothelial cells (1)
- epgenetics (1)
- epidemiology (1)
- epidermal growth factor (1)
- epithelial cells (1)
- excretory-secretory (1)
- expert recommendation (1)
- extracellular (1)
- eye infection (1)
- factor H (1)
- feasibility study (1)
- field gel-electrophoreresis (1)
- flatworm (1)
- flow cytometry (1)
- fluorescence microscopy (1)
- fungal antigens (1)
- fungal infection (1)
- fungal molecular diagnostics (1)
- fungi (1)
- fungicidal activity (1)
- galectin-2 (1)
- gangliosides and lipid rafts (1)
- gen (1)
- gene (1)
- general practice (1)
- general practitioner (1)
- generalized anxiety disorder (1)
- genetic loci (1)
- genetic variation (1)
- genetics (1)
- genome (1)
- genomic databases (1)
- genomic libraries (1)
- germinative cells (1)
- glucan synthase (1)
- glutamate dehydrogenase (1)
- glutathione (1)
- granulosus (1)
- group-B (1)
- heart (1)
- hematopoietic stem cell transplantation (1)
- hemihepatectomy (1)
- hospital-acquired methicillin-resistant Staphylococcus aureus (1)
- host defense (1)
- host response (1)
- host-pathogen interaction (1)
- host-pathogen interactions (1)
- host–pathogen interaction (1)
- human behaviour (1)
- human brain microvascular endothelial cells (1)
- hydatid disease (1)
- hydrogels (1)
- hyphae (1)
- identification (1)
- image processing (1)
- imaging (1)
- immune evasion (1)
- immune impairment (1)
- immune response (1)
- immunogenetics (1)
- immunology (1)
- immunomodulation (1)
- immunoprecipitation (1)
- immunotherapy (1)
- in vitro (1)
- in vivo (1)
- indigenous (1)
- induced pluripotent stem cells (1)
- infection prevention (1)
- infectious diseases management (1)
- innate immune evasions (1)
- innate immune response (1)
- interstage aspiration (1)
- intervention strategies (1)
- intravenous ceftriaxone (1)
- intravitreal vancomycin and amikacin (1)
- invasive aspergillosis (1)
- invasive disease (1)
- invasive fungal infection (1)
- invasive meningococcal disease (1)
- invasive pulmonary aspergillosis (1)
- jaw bone (1)
- joint aspiration (1)
- joint infection (1)
- keratitis (1)
- killing (1)
- knowledge (1)
- laboratory techniques and procedures (1)
- large animal models (1)
- larvae (1)
- leptomeningeal cells (1)
- leucocyte count (1)
- liver (1)
- liver resection (1)
- livestock-associated staphylococci (1)
- long noncoding RNA (1)
- longitudinal studies (1)
- mammalian genomics (1)
- mannan (1)
- marker (1)
- matrix metallopeptidase-1 (1)
- maximum liklihood (1)
- mebendazole (1)
- meningeal blood-csf barrier (1)
- meningococcal lineages (1)
- meningococcal polysaccharides (1)
- meningococcus (1)
- metabolism (1)
- metacestode vesicles (1)
- metamorphosis (1)
- methyltransferase homolog (1)
- micafungin (1)
- mice (1)
- microRNA (1)
- microbial surface component recognising adhesive matrix molecules (1)
- microbiological culture (1)
- microbiology techniques (1)
- microscopy (1)
- microvascular endothelial cells (1)
- microvascular endothelial-cells (1)
- mitochondria (1)
- mitochondrial dynamics (1)
- mitochondrial morphology (1)
- mobile crowdsensing (1)
- mobile health (1)
- molecular characterization (1)
- molecular epidemiology (1)
- monoclonal antibody (1)
- monocytes (1)
- mouse model (1)
- mouse models (1)
- multifaceted approaches (1)
- multiple myeloma (1)
- mycobacterial infection (1)
- mycophenolic acid (1)
- myocyte (1)
- natamycin (1)
- natural killer cell (1)
- natural transformation (1)
- neglected groups (1)
- neoblast (1)
- neonatal morbidity (1)
- nitrite respiration (1)
- nitrites (1)
- non-aureus staphylococci (1)
- nonautonomous (1)
- nosocomial transmission (1)
- nuclear magnetic resonance (1)
- ocular infection (1)
- one-health approach (1)
- oral cefpodoxime (1)
- oral doxycycline (1)
- oral microbiome (1)
- organic farming (1)
- organoid (1)
- outpatient (1)
- oxidative stress (1)
- panton-valentine leukocidin (1)
- paradoxical effect (1)
- paradoxical growth (1)
- parasitic diseases (1)
- pathometabolism (1)
- pediatric (1)
- pediatrician (1)
- periprosthetic joint infection (1)
- phase variation (1)
- phylotypic (1)
- pig (1)
- pig farming methods (1)
- piperacillin (1)
- piperacillin/tazobactam (1)
- planarian (1)
- plexus epithelial-cells (1)
- pluripotency (1)
- polymorphonuclear neutrophils (1)
- population biology (1)
- population genetics (1)
- post-operative antibiotic treatment (1)
- primary care (1)
- primary cells (1)
- probe-based real-time PCR (1)
- protein kinases (1)
- proteins (1)
- proteomic analysis (1)
- public health (1)
- qPCR (1)
- quality of life (1)
- real-time PCR (1)
- recombinant proteins (1)
- regulator (1)
- regulatory T cells (1)
- relA (1)
- research infrastructure (1)
- resistance (1)
- retrotransposition (1)
- revision arthroplasty (1)
- schistoma mansoni (1)
- sensitivity (1)
- sensitivity and specificity (1)
- septic (1)
- sequence (1)
- sequence assembly tools (1)
- serogroup B (1)
- serogroup-Y (1)
- seroprevalence (1)
- serum (1)
- single-molecule tracking (1)
- sirolimus (1)
- small RNA (1)
- small interfering RNAs (1)
- software (1)
- spa typing (1)
- sporidia (1)
- state-based model (1)
- stem cell transplantation (1)
- strain MC58 (1)
- strain specificity (1)
- stringent response (1)
- structural determination (1)
- super-resolution microscopy (1)
- surgical intra-abdominal infections (1)
- survey (1)
- systems biology (1)
- tapeworm (1)
- taxonomy (1)
- tazobactam (1)
- testing strategy (1)
- therapy (1)
- thermophile (1)
- throat (1)
- tight junctions (1)
- topic ofloxacin (1)
- transcription factors (1)
- translational research (1)
- transplantation (1)
- transposable elements (1)
- ultrahigh-field MRI (1)
- under five children (1)
- upper extremity (1)
- utilization (1)
- vaccine development (1)
- vaccines (1)
- vesicles (1)
- viral load (1)
- virulence (1)
- virulenceregulatory evolution (1)
- vitrectomy (1)
- water microbiology (1)
- white blood cell count (1)
- whole blood ex vivo model (1)
- whole-blood infection assay (1)
- whole-blood model (1)
- zinc cluster transcription factor (1)
- γ-glutamyl cycle (1)
Institute
- Institut für Hygiene und Mikrobiologie (120) (remove)
Sonstige beteiligte Institutionen
- Department of Hematology and Oncology, Sana Hospital Hof, Hof, Germany (1)
- Department of Laboratory Medicine and Medicine Huddinge, Karolinska Institutet and University Hospital, Stockholm, Sweden (1)
- Department of Medicine A, University Hospital of Münster, Münster, Germany (1)
- Krankenhaushygiene und Antimicrobial Stewardship (1)
- Krankenhaushygiene und Antimicrobial Stewardship (Universitätsklinikum) (1)
- Research Center for Infectious Diseases (ZINF), University of Würzburg, Würzburg, Germany (1)
EU-Project number / Contract (GA) number
- 2016 FGR 0053 (1)
- 278864 (1)
- 847507 (1)
High seroprevalence of SARS-CoV-2 in Mwanza, northwestern Tanzania: a population-based survey
(2022)
The transmission of the SARS-CoV-2 virus, which causes COVID-19, has been documented worldwide. However, the evidence of the extent to which transmission has occurred in different countries is still to be established. Understanding the magnitude and distribution of SARS-CoV-2 through seroprevalence studies is important in designing control and preventive strategies in communities. This study investigated the seropositivity of the SARS-CoV-2 virus antibodies in the communities of three different districts in the Mwanza region, Tanzania. A household cross-sectional survey was conducted in September 2021 using the modified African Centre for Disease and Prevention (ACDC) survey protocol. A blood sample was obtained from one member of each of the selected households who consented to take part in the survey. Immunochromatographic rapid test kits were used to detect IgM and IgG SARS-CoV-2 antibodies, followed by descriptive data analysis. Overall, 805 participants were enrolled in the study with a median age of 35 (interquartile range (IQR):27–47) years. The overall SARS-CoV-2 seropositivity was 50.4% (95%CI: 46.9–53.8%). The IgG and IgM seropositivity of the SARS-CoV-2 antibodies was 49.3% and 7.2%, respectively, with 6.1% being both IgG and IgM seropositive. A history of runny nose (aOR: 1.84, 95%CI: 1.03–3.5, p = 0.036), loss of taste (aOR: 1.84, 95%CI: 1.12–4.48, p = 0.023), and living in Ukerewe (aOR: 3.55, 95%CI: 1.68–7.47, p = 0.001) and Magu (aOR: 2.89, 95%CI: 1.34–6.25, p= 0.007) were all independently associated with SARS-CoV-2 IgM seropositivity. Out of the studied factors, living in the Ukerewe district was independently associated with IgG seropositivity (aOR 1.29, CI 1.08–1.54, p = 0.004). Twenty months after the first case of COVID-19 in Tanzania, about half of the studied population in Mwanza was seropositive for SARS-CoV-2.
Candida auris was first described as a yeast pathogen in 2009. Since then, the species has emerged worldwide. In contrast to most other Candida spp., C. auris frequently exhibits multi-drug resistance and is readily transmitted in hospital settings. While most detections so far are from colonised patients, C. auris does cause superficial and life-threatening invasive infections. During management of the first documented C. auris transmission in a German hospital, experts from the National Reference Centers for Invasive Fungal Infections (NRZMyk) and the National Reference Center for Surveillance of Nosocomial Infections screened available literature and integrated available knowledge on infection prevention and C. auris epidemiology and biology to enable optimal containment. Relevant recommendations developed during this process are summarised in this guidance document, intended to assist in management of C. auris transmission and potential outbreak situations. Rapid and effective measures to contain C. auris spread require a multi-disciplinary approach that includes clinical specialists of the affected unit, nursing staff, hospital hygiene, diagnostic microbiology, cleaning staff, hospital management and experts in diagnostic mycology / fungal infections. Action should be initiated in a step-wise process and relevant interventions differ between management of singular C. auris colonised / infected patients and detection of potential C. auris transmission or nosocomial outbreaks.
Diagnosis and therapy of Mycobacterium marinum: a single-center 21-year retrospective analysis
(2022)
Background and Objectives
In Europe, infections with Mycobacterium (M.) marinum are rare. We conducted a retrospective single-center study to assess the clinical spectrum of M. marinum infection and its diagnosis, treatment and outcome under real-world conditions.
Patients and Methods
Eighteen patients presenting with M. marinum infections between 1998 and 2018 were identified in the data warehouse of the University Hospital Würzburg and considered for detailed analysis.
Results
Twelve patients reported aquatic exposure. In 16/18 cases the upper extremities were affected. No invasive infections were detected. Mean time to diagnosis was 15 weeks. Histology revealed granulomatous inflammation in 14 patients while mycobacterial cultures were positive for M. marinum in 16 cases. Most patients received antibiotic monotherapy (14/18) while combination therapy was administered in four cases. Treatment (with a median duration of 10 weeks) was successful in 13 patients. Five patients were lost to follow-up.
Conclusions
Our retrospective analysis of M. marinum infections at a German tertiary referral center revealed a considerable diagnostic delay and the relevance of microbiological culture, PCR and histology for diagnosis. Monotherapy with clarithromycin (rather than doxycycline) appeared as a reasonable treatment option while immunosuppressed or -compromised patients and those with extended disease received combination therapy.
Purpose
Fungal biomarkers support early diagnosis of invasive fungal infections. In this study, we evaluated the impact of a recent update to the manufacturer‐recommended cut‐off for beta‐1,3‐D‐glucan (BDG) testing (Fujifilm Wako BDG assay) on sensitivity and specificity for the detection of candidemia. Additionally, we compared the performance with tests for Candida antigen (Ag by Serion ELISA antigen Candida, Virion\Serion) and anti‐mannan antibodies (Ab by Hemkit Candida IHA, Ravo Diagnostika).
Methods
Sera of 82 patients with candidemia, which were sampled with a maximum distance of ±14 days from the date of sampling of the corresponding positive blood cultures, were retrospectively analysed for BDG, Ag and Ab. Results of BDG testing were compared with results from sera of 129 patients with candidemia from a different hospital.
Results
Sensitivity of BDG testing (47%) was higher than for Ag (17%) or Ab (20%). By combining Ag and Ab testing, sensitivity was raised to 32%. Lowering the cut‐off of BDG from 11 pg/ml to the newly recommended cut‐off of 7 pg/ml resulted in a significant increase in sensitivity (47% vs 58%, p = .01 and 63% vs 71% p < .01). At both centres, the increase was significant in NAC but not in C. albicans candidemia. No significant effects on specificity were observed.
Conclusion
BDG testing outperformed Ag and Ab testing and its combination. Lowering the BDG cut‐off had no significant impact on specificity. The increase in sensitivity can be mainly attributed to a gain in sensitivity for non‐albicans Candida species bloodstream infections.
The Indigenous tribe called the Wiwa lives retracted in the Sierra Nevada de Santa Marta, Colombia. Little is known about their health status and whether the health care system in place covers their needs. In 2017 and 2018, a permanent physician was in charge for the Wiwa. Diseases and complaints were registered, ranked, and classified with the ICD-10 coding. Datasets from the Indigenous health care provider Dusakawi, collected from local health points and health brigades travelling sporadically into the fields for short visits, were compared. Furthermore, a list of provided medication was evaluated regarding the recorded needs. The most common complaints found were respiratory, infectious and parasitic, and digestive diseases. The top ten diagnoses collected in the health points and in the health brigade datasets were similar, although with a different ranking. The available medication showed a basic coverage only, with a critical lack of treatment for many severe, chronic, and life-threatening diseases. Most of the detected diseases in the Indigenous population are avoidable by an improvement in health care access, an expansion of the provided medication, and an increase in knowledge, hygiene, and life standards.
Outpatient antibiotic use is closely related to antimicrobial resistance and in Germany, almost 70% of antibiotic prescriptions in human health are issued by primary care physicians (PCPs). The aim of this study was to explore PCPs, namely General Practitioners' (GPs) and outpatient pediatricians' (PDs) knowledge of guideline recommendations on rational antimicrobial treatment, the determinants of confidence in treatment decisions and the perceived need for training in this topic in a large sample of PCPs from southern Germany. Out of 3753 reachable PCPs, 1311 completed the survey (overall response rate = 34.9%). Knowledge of guideline recommendations and perceived confidence in making treatment decisions were high in both GPs and PDs. The two highest rated influencing factors on prescribing decisions were reported to be guideline recommendations and own clinical experiences, hence patients' demands and expectations were judged as not influencing treatment decisions. The majority of physicians declared to have attended at least one specific training course on antibiotic use, yet almost all the participating PCPs declared to need more training on this topic. More studies are needed to explore how consultation-related and context-specific factors could influence antibiotic prescriptions in general and pediatric primary care in Germany beyond knowledge. Moreover, efforts should be undertaken to explore the training needs of PCPs in Germany, as this would serve the development of evidence-based educational interventions targeted to the improvement of antibiotic prescribing decisions rather than being focused solely on knowledge of guidelines.
Fungal eye infections can lead to loss of vision and blindness. The disease is most prevalent in the tropics, although case numbers in moderate climates are increasing as well. This study aimed to determine the dominating filamentous fungi causing eye infections in Germany and their antifungal susceptibility profiles in order to improve treatment, including cases with unidentified pathogenic fungi. As such, we studied all filamentous fungi isolated from the eye or associated materials that were sent to the NRZMyk between 2014 and 2020. All strains were molecularly identified and antifungal susceptibility testing according to the EUCAST protocol was performed for common species. In total, 242 strains of 66 species were received. Fusarium was the dominating genus, followed by Aspergillus, Purpureocillium, Alternaria, and Scedosporium. The most prevalent species in eye samples were Fusarium petroliphilum, F. keratoplasticum, and F. solani of the Fusarium solani species complex. The spectrum of species comprises less susceptible taxa for amphotericin B, natamycin, and azoles, including voriconazole. Natamycin is effective for most species but not for Aspergillus flavus or Purpureocillium spp. Some strains of F. solani show MICs higher than 16 mg/L. Our data underline the importance of species identification for correct treatment.
Despite available diagnostic tests and recent advances, diagnosis of pulmonary invasive aspergillosis (IPA) remains challenging. We performed a longitudinal case-control pilot study to identify host-specific, novel, and immune-relevant molecular candidates indicating IPA in patients post allogeneic stem cell transplantation (alloSCT). Supported by differential gene expression analysis of six relevant in vitro studies, we conducted RNA sequencing of three alloSCT patients categorized as probable IPA cases and their matched controls without Aspergillus infection (66 samples in total). We additionally performed immunoassay analysis for all patient samples to gain a multi-omics perspective. Profiling analysis suggested LGALS2, MMP1, IL-8, and caspase-3 as potential host molecular candidates indicating IPA in investigated alloSCT patients. MMP1, IL-8, and caspase-3 were evaluated further in alloSCT patients for their potential to differentiate possible IPA cases and patients suffering from COVID-19-associated pulmonary aspergillosis (CAPA) and appropriate control patients. Possible IPA cases showed differences in IL-8 and caspase-3 serum levels compared with matched controls. Furthermore, we observed significant differences in IL-8 and caspase-3 levels among CAPA patients compared with control patients. With our conceptual work, we demonstrate the potential value of considering the human immune response during Aspergillus infection to identify immune-relevant molecular candidates indicating IPA in alloSCT patients. These human host candidates together with already established fungal biomarkers might improve the accuracy of IPA diagnostic tools.
Background
Joint aspiration with analysis of synovial fluid white blood cell count (WBC) and microbiological culture is a widely established aspect in the diagnosis of shoulder joint infections (SJI). In case of a two stage revision for SJI, joint aspiration before re−/implantation of a total shoulder arthroplasty (TSA) was used to rule out persistent infection for years but its value is under debate. Shoulder specific data on all aspects is rare. The current study aims to answer the following research questions: Does joint aspiration have an insufficient predictive value in the diagnosis of SJI in (1) initial workup and (2) before definite arthroplasty with polymethylmethacrylate (PMMA)-Spacer in place?
Methods
This retrospective evaluation investigates 35 patients that were treated for SJI with a two staged implantation of a TSA after debridement and implantation of an PMMA-Spacer. Joint aspirations were performed preoperatively (PA) and before re−/implantation of the prosthesis while spacer was in place (interstage aspiration, IA). Samples were taken for microbiological culture and analysis of WBC. Sensitivity and specificity were calculated with reference to intraoperative microbiological samples. Receiver Operating Characteristic (ROC), Area-Under-Curve analysis (AUC) and calculation of the Youden index were performed to find optimum cut-off for WBC.
Results
The sensitivity of microbiological cultures from PA was 58.3% and the specificity was 88.9%. The mean WBC was 27,800 leucocytes/mm3 (range 400-96,300). The maximum Youden index (0.857) was a cut-off of 2600 leucocytes/mm3 with a sensitivity of 85.7% and a specificity of 100.0%. The sensitivity and specificity of IA were 0.0% and 88.5%, respectively.
Conclusions
Preoperative aspiration is likely to miss Cutibacteria spp. and CoNS and cannot rule out infection for sure. However, we recommend it for its advantages of targeted antibiotic therapy in case of germ identification. Empiric antibiotic therapy should cover Cutibacteria and CoNS even if aspiration showed negative microbiological cultures. In contrast, the diagnostic value of interstage aspiration does not qualify for its routine use.